头颈癌放疗后晚期口干与唾液分泌减少的患病率及相关危险因素:多中心横断面研究
该多中心横断面研究纳入260例头颈癌放疗后1年随访患者,采用SXI、CODS和UWS评估口干及唾液流率。结果显示78%患者报告口干,女性、高龄、晚期肿瘤、高放疗剂量及同步放化疗与更严重的口干和唾液分泌减少显著相关。
要点
- 头颈癌放疗后1年口干患病率高达78%。
- 女性、高龄、晚期肿瘤及高放疗剂量与更严重口干相关。
- 同步放化疗与唾液流率下降及口干加重显著相关。
核心结论
- 头颈癌幸存者中口干和唾液分泌减少患病率高,严重程度与晚期肿瘤分期、较高放疗剂量及同步放化疗显著相关。
研究设计与样本
- 观察性多中心横断面研究,纳入260例头颈癌放疗后1年随访患者,进行主观口干评分(SXI)、临床口腔干燥评分(CODS)和非刺激唾液流率(UWS)评估。
主要发现
- 78%的患者报告口干,50岁以上患者严重程度更高(均值±标准差:13.53±1.09)。
- 女性唾液流率较低(UWS:r=0.556,p<0.0001),口干评分较高(SXI:r=0.337,CODS:r=0.359)。
- 肿瘤部位与口干强相关(SXI:r=0.894,p<0.001),口腔肿瘤比鼻咽肿瘤影响更严重。
- 较高放疗剂量和分次与UWS负相关(r=-0.537,p<0.0001),与SXI(r=0.293)和CODS(r=0.405,p<0.0001)正相关。
- 回归模型显示晚期肿瘤分期、女性、高龄和较高放疗剂量暴露可显著预测口干严重程度。
临床怎么用
- 了解相关危险因素有助于指导早期干预和个体化管理,以改善长期口腔健康结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to assess the prevalence and risk factors associated with late xerostomia and hyposalivation in head and neck cancer (HNC) patients after radiotherapy (RT). MATERIALS AND METHODS: An observational, multicentric cross-sectional study was conducted on 260 HNC patients attending various radiation centers for follow up 1-year post-treatment. Clinical assessments included the Subjective Dry Mouth Score (SXI), Clinical Oral Dryness Score (CODS), and Unstimulated Salivary Flow Rate (UWS). RESULTS: Xerostomia was reported by 78% of patients, with higher severity in those over 50 years (Mean ± SD: 13.53 ± 1.09). Women showed lower salivary flow (UWS: r = 0.556, p < 0.0001) and higher xerostomia scores (SXI: r = 0.337, CODS: r = 0.359) than men. Tumor site correlated strongly with xerostomia (SXI: r = 0.894, p < 0.001), with oral cavity tumors showing more severe effects than nasopharyngeal tumors. Higher RT dose and fraction were negatively associated with UWS (r = -0.537, p < 0.0001) and positively correlated with SXI (r = 0.293) and CODS (r = 0.405, p < 0.0001). The regression models showed that xerostomia severity is significantly predicted by advanced tumor stage, female gender, older age, and higher radiation dose exposure. CONCLUSIONS: The study reveals a high prevalence of xerostomia and hyposalivation among HNC survivors. Increased xerostomia severity and decreased salivary flow were significantly associated with advanced tumor stage, higher radiation doses, and concurrent chemoradiotherapy. CLINICAL RELEVANCE: Understanding risk factors can guide early interventions and personalized management to enhance long-term oral health outcomes.
引用
- Abou-Bakr A, Hassanein FEA, William H, et al. Prevalence of late xerostomia and hyposalivation with associated risk factors in survivors of head and neck cancer after radiotherapy: a multi-centric cross-sectional study. Radiat Oncol. 2025. PMID: 41204325. doi:10.1186/s13014-025-02737-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。